🇯🇵 Doxorubicin Hydrochloride in Japan

PMDA authorised Doxorubicin Hydrochloride on 1 March 1975

Marketing authorisation

PMDA — authorised 1 March 1975

  • Marketing authorisation holder: SANDOZ PHARMA K.K.
  • Status: approved

Doxorubicin Hydrochloride in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Japan

Frequently asked questions

Is Doxorubicin Hydrochloride approved in Japan?

Yes. PMDA authorised it on 1 March 1975.

Who is the marketing authorisation holder for Doxorubicin Hydrochloride in Japan?

SANDOZ PHARMA K.K. holds the Japanese marketing authorisation.